Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Application | Utility: RODENT MODEL OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA Filling date: 12 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Isolating Cells Expressing Secreted Proteins Filling date: 12 Sep 2025 Issue date: 12 Dec 2019 |
Grant | Utility: Human antibodies to Ebola virus glycoprotein Filling date: 12 Sep 2025 Issue date: 10 Dec 2019 |
Application | Utility: Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: METHODS AND SYSTEMS FOR SPARSE VECTOR-BASED MATRIX TRANSFORMATIONS Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: Methods for Treating Skin Infection by Administering an IL-4R Antagonist Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Utility: Humanized C5 animals Filling date: 12 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 Filling date: 12 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGF Filling date: 12 Sep 2025 Issue date: 28 Nov 2019 |
Grant | Utility: Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor Filling date: 12 Sep 2025 Issue date: 26 Nov 2019 |
Application | Utility: Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike Protein Filling date: 12 Sep 2025 Issue date: 21 Nov 2019 |
Grant | Utility: Humanized IL-4 and IL-4R.alpha. animals Filling date: 12 Sep 2025 Issue date: 19 Nov 2019 |
Application | Utility: METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 12 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULATIONS Filling date: 12 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: SYSTEMS AND METHODS FOR QUANTIFYING AND MODIFYING PROTEIN VISCOSITY Filling date: 12 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: HUMANIZED IL-7 RODENTS Filling date: 12 Sep 2025 Issue date: 14 Nov 2019 |
Grant | Utility: Method for making a genetically modified mouse with an inducible ACVR1 mutation that causes ectopic bone formation Filling date: 12 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Stabilized formulations containing anti-PCSK9 antibodies Filling date: 12 Sep 2025 Issue date: 12 Nov 2019 |
Application | Utility: METHODS FOR EVALUATING SUITABILITY OF A BIOCHEMICAL FILTER Filling date: 12 Sep 2025 Issue date: 7 Nov 2019 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Rodent model of steel syndrome Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Maytansinoid derivatives, conjugates thereof, and methods of use Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Human antibodies to S. aureus Hemolysin A toxin Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Genetically modified non-human animals expressing human EPO Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Application | Utility: Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations Filling date: 12 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: MEDICAL IMAGING TABLE, TABLE SUPPORT ASSEMBLY, PROBE SUPPORT ASSEMBLY, SYSTEM, AND METHOD OF USE Filling date: 12 Sep 2025 Issue date: 31 Oct 2019 |
Grant | Utility: Efficient selectivity of recombinant proteins Filling date: 12 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Methods of treating skin cancer by administering a PD-1 inhibitor Filling date: 12 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Methods and compositions for targeted genetic modification using paired guide RNAs Filling date: 12 Sep 2025 Issue date: 29 Oct 2019 |
Application | Utility: TARGETED MODIFICATION OF RAT GENOME Filling date: 12 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist Filling date: 12 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3 Filling date: 12 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Rodent embryonic stem cell with conditional ACVR1 mutant alleles Filling date: 12 Sep 2025 Issue date: 22 Oct 2019 |
Application | Utility: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: GENETIC MODIFICATION OF RATS Filling date: 12 Sep 2025 Issue date: 17 Oct 2019 |
Grant | Utility: Anti-Tie2 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Oct 2019 |
Grant | Utility: Methods of treating obesity with anti-ANGPTL8 antibodies Filling date: 12 Sep 2025 Issue date: 15 Oct 2019 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY Filling date: 12 Sep 2025 Issue date: 10 Oct 2019 |
Grant | Utility: Humanized IL-6 and IL-6 receptor Filling date: 12 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies Filling date: 12 Sep 2025 Issue date: 8 Oct 2019 |
Application | Utility: Genetically Modified Mice and Engraftment Filling date: 12 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 12 Sep 2025 Issue date: 3 Oct 2019 |
Grant | Utility: Non-human animals having a humanized signal-regulatory protein gene Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Fusion polypeptides capable of activating receptors Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Humanized Fc.gamma.R mice Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Methods and compositions for generating or maintaining pluripotent cells Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Dosing regimens for use with PCSK9 inhibitors Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Showing 600 to 650 of 704 patents.